'One-month daily and three-month weekly rifapentine plus isoniazid are comparable in completion rate and safety for latent tuberculosis infection in non-HIV Population: a randomized controlled trial' - author's response

Clin Microbiol Infect. 2024 Nov;30(11):1482-1483. doi: 10.1016/j.cmi.2024.08.009. Epub 2024 Aug 20.
No abstract available

Publication types

  • Letter